Drug Shortage Report for APO-NAPROXEN EC

Last updated on 2020-02-01 History
Report ID 103370
Drug Identification Number 02246701
Brand name APO-NAPROXEN EC
Common or Proper name NAPROXEN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size 100 BTL
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-01-13
Estimated end date 2020-02-03
Actual end date 2020-01-31
Shortage status Resolved
Updated date 2020-02-01
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2020-02-01 English Compare
v7 2020-01-31 French Compare
v6 2020-01-31 English Compare
v5 2020-01-15 French Compare
v4 2020-01-15 English Compare
v3 2020-01-15 English Compare
v2 2020-01-15 French Compare
v1 2020-01-15 English Compare